• DexCom Executive Chair Kevin R. Sayer sold 26,756 common shares on Aug. 20, 2026 at about $89.71 to $91.41.
• His direct holdings fell to 302,214 shares following the transactions.
• The sales were priced at weighted-average levels, including $89.71 and $90.78 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001093557-26-000151), on August 24, 2026, and is solely responsible for the information contained therein.